Replay available

Minerva Neurosciences, Inc (NERV) Q1 2023 Earnings Call

Minerva Neurosciences, Inc (NASDAQ: NERV) Q1 2023 earnings conference call, held 2023-05-15. Replay captured from the company's public earnings webcast.

Mon, May 15, 2023 at 8:30 AMendedReplay
Minerva Neurosciences, Inc (NERV) Q1 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Andrew Sy

Analyst, Jefferies

Douglas Sal

Analyst, H.C. Wainwright

Fred Alholm

Senior Vice President and Chief Financial Officer

Dr. Remy Lutringer

Executive Chairman and Chief Executive Officer

Jeff Reiss

President

Replay transcript excerpt

Welcome to the Minerva Neurosciences first quarter 2023 conference call. At this time, all participants are in a listen-only mode. There will be a question and answer session following today's prepared remarks. This call is being webcast live on the Investors section of Minerva's website at ir.minervaneurosciences.com. As a reminder, today's call is being recorded. I would now like to turn the call over to Jeff Reiss, President of Minerva Neurosciences. Please go ahead. Good morning. A press release with the company's first quarter 2023 financial results and business highlights became available at 7.30 a.m. Eastern Time today and can be found on the Investors section of our website. Our quarterly report on Form 10Q was also filed electronically with the Securities and Exchange Commission this morning and can be found on the SEC's website at www.sec.gov. Joining me on the call today from Minerva are Dr. Remy Lutringer, Executive Chairman and Chief Executive Officer, and Mr. Fred Alholm, Senior Vice President and Chief Financial Officer. Following our prepared remarks, we will open the call for Q&A. Before we begin, I would like to remind you that today's discussion will include statements about the company's future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. We caution that these forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated. These forward looking statements are based on our current expectations and may differ materially from actual results due to a variety of factors that are more fully detailed under the caption risk factors in our filings w...

More from Minerva Neurosciences, Inc